
AI Powered Robotic Labs Developing Next Gen Antiviral Compounds Autonomously
In recent years, the convergence of artificial intelligence (AI) and robotics has ushered in a new era for pharmaceutical research, particularly in the development of antiviral compounds. AI-powered robotic labs are now capable of autonomously conducting experiments and analyzing data at an unprecedented scale, promising faster and more efficient drug discovery processes.